Neuropharmacology in Pediatric Brain Injury: A Review
Authors:
- Angela Giacoletti‐ArgentoAGAngela Giacoletti‐Argento
- Renee ShellhaasRSRenee Shellhaas
- Edward A. HurvitzEHEdward A. Hurvitz
- Joseph Edward HornyakJHJoseph Edward Hornyak
Abstract
In this review, the current evidence is examined regarding neuropharmacologic treatment for children and adolescents (under the age of 18 years) who sustained a traumatic brain injury (TBI). Although the focus is on the pediatric TBI population, there is a paucity of empirical data related to the role of medication with children and adolescents after brain injury. Therefore, findings from the adult TBI literature are incorporated where appropriate so as to identify potential agents that warrant further examination in pediatric populations. This review addresses specific sequelae of TBI from the earliest stages of neurologic recovery to long‐term comorbidities, including disorders of impaired consciousness, post‐TBI agitation, cognitive decline, and post‐TBI depression. The evidence regarding the role of medication in neuroprotection and neurorecovery in this population is also explored. Medication classes reviewed include excitatory amino acids, antagonists to the N‐methyl‐D‐aspartate receptor, dopamine agonists, benzodiazepines, β‐blockers, anticonvulsants, and antidepressants. It is hoped that this review will guide future research, and ideas as to how this may be accomplished within a pediatric population are suggested.Keywords
This publication has 107 references indexed in Scilit:
- New Concepts in Treatment of Pediatric Traumatic Brain InjuryAnesthesiology Clinics, 2009
- Incidence of Clinically Significant Responses to Zolpidem Among Patients with Disorders of ConsciousnessAmerican Journal of Physical Medicine & Rehabilitation, 2009
- Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injuryNeuroscience Letters, 2008
- Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficitsLife Sciences, 2008
- Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain traumaCritical Care Medicine, 2007
- The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical PracticeEpilepsia, 2006
- Executive Functions After Traumatic Brain Injury in ChildrenPediatric Neurology, 2005
- Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonistsMetabolic Brain Disease, 1996
- Prescribing of potentially harmful drugs to patients admitted to hospital after head injury.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Clinical Pharmacokinetics of Amantadine HydrochlorideClinical Pharmacokinetics, 1988